Get the Stockscreener App
7.60
7.20%
-0.59
After Hours:
7.40
-0.20
-2.63%
Wave Life Sciences Ltd stock is traded at $7.60, with a volume of 3.16M.
It is down -7.20% in the last 24 hours and up +2.84% over the past month.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
See More
Previous Close:
$8.19
Open:
$8.28
24h Volume:
3.16M
Relative Volume:
1.56
Market Cap:
$1.21B
Revenue:
$93.95M
Net Income/Loss:
$-129.87M
P/E Ratio:
-8.4444
EPS:
-0.9
Net Cash Flow:
$-202.88M
1W Performance:
+6.29%
1M Performance:
+2.84%
6M Performance:
+38.69%
1Y Performance:
-7.99%
1-Day Range:
$7.41
$8.28
1-Week Range:
$7.07
$8.33
52-Week Range:
$5.28
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences Ltd
Sector
Industry
Phone
617-949-2900
Address
7 STRAITS VIEW, SINGAPORE
Compare WVE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
7.60 | 1.30B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Initiated | Canaccord Genuity | Buy |
| Jul-28-25 | Initiated | Oppenheimer | Outperform |
| Jul-16-25 | Initiated | Citigroup | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-25 | Initiated | Wedbush | Outperform |
| Feb-25-25 | Initiated | Jefferies | Buy |
| Oct-16-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-27-24 | Resumed | JP Morgan | Overweight |
| Sep-19-24 | Initiated | B. Riley Securities | Buy |
| Sep-09-24 | Initiated | JP Morgan | Overweight |
| May-15-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-23 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-05-23 | Initiated | Raymond James | Outperform |
| May-24-23 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-20 | Resumed | H.C. Wainwright | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-31-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-01-19 | Initiated | Guggenheim | Buy |
| Jul-15-19 | Initiated | Cowen | Market Perform |
| Apr-17-19 | Reiterated | H.C. Wainwright | Buy |
| Aug-07-18 | Initiated | Stifel | Buy |
| Jul-23-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Feb-15-17 | Initiated | H.C. Wainwright | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | JMP Securities | Mkt Outperform |
| Dec-07-15 | Initiated | Jefferies | Buy |
| Dec-07-15 | Initiated | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Wave Life Sciences Ltd Stock (WVE) Latest News
What the charts say about Wave Life Sciences Ltd. todayJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
A Look at Wave Life Sciences’s (WVE) Valuation Following Excitement Over PRISM Platform Progress and RNA Pipeline Momentum - simplywall.st
Why analysts upgrade Wave Life Sciences Ltd. stockTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 5.3%Here's What Happened - MarketBeat
Could Investor Optimism Around Wave Life Sciences’ PRISM Platform Reveal a Turning Point for WVE? - simplywall.st
WAVE Life Sciences (NASDAQ:WVE) Trading Up 9.3%Should You Buy? - MarketBeat
Wave Life Sciences (WVE): A Valuation Deep Dive Following Pipeline Progress and Investor Optimism - Yahoo Finance
Full technical analysis of Wave Life Sciences Ltd. stock2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength? - Nasdaq
Has Wave Life Sciences Ltd. formed a bullish divergencePortfolio Gains Report & Low Risk High Win Rate Stock Picks - newser.com
What analysts say about Wave Life Sciences Ltd stockStop Loss Placement Tips & Discover Strategies with Fellow Traders - earlytimes.in
Wave Life Sciences Ltd 1U5 Stock Analysis and ForecastPortfolio Allocation Tips & Invest Now – Opportunity Window Closing - earlytimes.in
Will Wave Life Sciences Ltd. (1U5) stock enhance shareholder valueJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com
Why Wave Life Sciences Ltd. (1U5) stock is a strong buy callWeekly Loss Report & Reliable Trade Execution Plans - newser.com
Can technical indicators confirm Wave Life Sciences Ltd.’s reversalJuly 2025 Review & Expert Approved Momentum Ideas - newser.com
How Wave Life Sciences Ltd. (1U5) stock reacts to Fed tighteningQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
WAVE Life Sciences' (WVE) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Wave Life Sciences Ltd. Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo
Wave Life Sciences Ltd.’s volatility index tracking explainedJuly 2025 Opening Moves & Reliable Trade Execution Plans - newser.com
Is Wave Life Sciences Ltd. stock a contrarian buy2025 Price Targets & Low Drawdown Investment Strategies - newser.com
Key metrics from Wave Life Sciences Ltd.’s quarterly dataTrade Analysis Summary & Safe Entry Point Identification - newser.com
Will Wave Life Sciences Ltd. stock recover after recent dropMarket Trend Report & Weekly Market Pulse Alerts - newser.com
How Wave Life Sciences Ltd. stock benefits from strong dollarWeekly Investment Report & Reliable Entry Point Alerts - newser.com
Tools to monitor Wave Life Sciences Ltd. recovery probabilityQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
WAVE Life Sciences Ltd. $WVE Stake Raised by Platinum Investment Management Ltd. - MarketBeat
Wave Life Sciences Hits Day High with 7.65% Surge in Stock Price - Markets Mojo
Wave Life Sciences at Stifel Forum: Targeting Obesity with siRNA By Investing.com - Investing.com Canada
Wave Life Sciences at Stifel Forum: Targeting Obesity with siRNA - Investing.com India
Wave Life Sciences Rockets 70% on Historic RNA Editing Success - MSN
Wave Life Sciences Ltd Stock (WVE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Wave Life Sciences Ltd Stock (WVE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BOLNO PAUL | President and CEO |
Aug 22 '25 |
Sale |
10.10 |
217,351 |
2,194,810 |
121,000 |
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):